Theranostics · 2019 · 68 citations · 39 references
PharmacyBioengineeringPharmaceuticsBiocompatibilityDrug DeliveryNanoparticle Drug DeliveryDrug Delivery BiomaterialsDrug EncapsulationNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanoparticle DesignNanostructured BiomaterialsBone Resorption InhibitionLocal Drug Delivery SystemsMesoporous Silica NanoparticlesNanomaterials For Bone RegenerationOsteoclast InhibitionOsteoclast-mediated Bone DestructionOsteoclast-mediated Bone LossOsteoclast-mediated Bone Remodeling
: Licorice ISL-encapsulated MSNs exhibit notable anti-osteoclastogenetic effects and protect against inflammatory bone destruction. Our findings reveal the feasibility of applying MSNs-ISL as an effective natural product-based bone-bioresponsive nanoencapsulation system to prevent osteoclast-mediated bone loss.
39
George R. Beck, Shin‐Woo Ha, Corinne E. Camalier et al. · Nanomedicine Nanotechnology Biology and Medicine · 2011 · 269 citations · Full text
RANK‐mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis
Jin Gohda, T. Akiyama, Takako Koga et al. · The EMBO Journal · 2005 · 224 citations · Full text
Jinghan Su, Huiping Sun, Qingshuo Meng et al. · Theranostics · 2017 · 208 citations · Full text